Iodine Market Analysis

Source: https://www.fortunebusinessinsights.com/jp/%E3%83%A8%E3%82%A6%E7%B4%A0%E5%B8%82%E5%A0%B4-103889

Market Overview

The global iodine market was valued at USD 2.12 billion in 2025 and is projected to grow from USD 1.97 billion in 2026 to USD 2.74 billion by 2034, registering a CAGR of 6.60% during the forecast period (2026–2034). Europe dominated the market in 2025, holding a 40.40% share, valued at USD 0.85 billion.

Iodine is a stable halogen element with a lustrous purple hue. It serves a wide range of industrial and medical purposes — from acting as a catalyst in polymer manufacturing to functioning as an additive in animal feed. The growing global demand for iodine is driven by its critical role in polarizing films, X-ray contrast media, and pharmaceutical applications.

Key Market Drivers

Rising Prevalence of Chronic Diseases: The increasing incidence of chronic conditions is fueling demand for iodine-based X-ray contrast media. Diagnostic procedures such as CT scans, angiography, and interventional radiology rely heavily on iodine-based contrast agents to enhance image clarity and diagnostic accuracy. Advancements in AI-powered imaging and high-resolution CT scanners are further boosting this segment.

Consumer Electronics & Battery Technology: Growing demand for LCD and OLED display devices — including smartphones, tablets, and televisions — is driving iodine use in optical polarizing films. Additionally, as the world shifts toward renewable energy and electric vehicles, iodine-based battery technologies are emerging as a promising opportunity for energy storage solutions.

Health Awareness & WHO Initiatives: Increasing awareness of iodine deficiency among aging populations, along with WHO-backed programs aimed at reducing deficiencies in economically developing countries, is supporting market growth — especially in the human nutrition segment.

Market Restraints

Excessive iodine consumption can cause toxicity, leading to adverse effects such as nausea, airway swelling, weakened pulse, and hyperthyroidism — particularly dangerous for individuals with cardiac conditions. Low consumer awareness about safe dosage levels continues to act as a restraint on market expansion.

Segmentation Analysis

By Source: Caliche ore (from Chile's Atacama Desert) dominated due to cost-effective extraction. Underground brines are significant in the US, Japan, and Azerbaijan. Seaweed is the fastest-growing source, driven by its vital role in thyroid function and overall health.

By Application: X-ray contrast media holds the largest application share. The pharmaceuticals segment accounted for 14% share in 2023. Human nutrition and biocides are the fastest-growing segments, fueled by rising hygiene awareness and iodine deficiency concerns.

Regional Insights

• Europe leads globally, valued at USD 0.76 billion in 2023. Government healthcare spending supports strong demand in pharmaceuticals and contrast media. Germany's pharma segment held a 14.5% share in 2023.
• Asia Pacific is the fastest-growing region, propelled by rising iodine deficiency awareness and demand from animal feed, fluorochemicals, and optical polarizing film applications. Japan is a major producer via underground brine extraction.
• North America benefits from high demand in pharma and disinfectant manufacturing.
• Latin America is led by Chile, which dominates global iodine production through Caliche ore extraction.

Key Players

The global market is fairly consolidated. Leading players include:

• Cosayach Compañía de Salitre y Yodo (Chile)
• SQM S.A. (Chile)
• ISE Chemicals Corporation (Japan)
• Algorta Norte S.A. (Chile)
• Toho Earthtech Co., Ltd. (Japan)
• Iofina plc (UK)

Notable Developments:

• July 2023: Iofina announced construction of a new plant in Oklahoma, expected to produce 100–150 MT of crystalline iodine annually.
• October 2022: SQM S.A. signed a multi-year agreement with GE Healthcare to supply iodine for contrast media used in CT imaging.

Report Scope